Prof. Yushun Gao 高禹舜
Chief Physician, Professor
Department of Thoracic Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of lung cancer, benign lung tumors, esophageal cancer, cardia cancer, mediastinal tumors (thymoma, teratoma), and chest wall tumors.
Dr. Gao is Deputy Director of Thoracic Surgery, Chief Physician, Professor, and Master’s supervisor at Cancer Hospital, Chinese Academy of Medical Sciences. Dr. Gao holds a PhD in Medical Oncology from Peking Union Medical College. Clinical focus includes thoracic tumors, with expertise in complex cases, VATS lung cancer resection, and minimally invasive esophageal cancer surgery. Dr. Gao has published over 20 papers and served as sub-project leader for two National 863 Program projects.
Professional roles
- Member, Medical Malpractice Appraisal Expert Database, Beijing Medical Association
- Editorial Board Member, Chinese Journal of Multiple Organ Diseases in the Elderly
Name order: in Chinese the family name comes first (Gao Yushun). Papers usually list the name as Yushun Gao or Gao Y.
Selected publications
92 papers on PubMed matched by name and affiliation; 33 as first or senior author since 2016. Most recent first- or senior-author papers:
- Transl Lung Cancer Res, 2026 (senior author): Adjuvant chemotherapy and survival after resection for pulmonary large-cell neuroendocrine carcinoma: a dual-center time-dependent analysis. PubMed 42723785
- Cancers (Basel), 2026 (senior author): Unveiling Lipid Metabolism-Related Gene PTGDS: A Tumor Suppressor in Lung Adenocarcinoma with Therapeutic Potential. PubMed 42352418
- NPJ Prim Care Respir Med, 2026 (senior author): The "Asian Paradox" in multiple primary lung cancer: a geographic monopole driven by phenotypic divergence. PubMed 41942506
- J Cardiothorac Surg, 2025 (senior author): Plasma metabolites as biomarkers for screening and differential diagnosis of lung cancer. PubMed 41366469
- Front Immunol, 2025 (senior author): Identification of MUC5B as a lymph node metastasis-associated gene in lung adenocarcinoma through integrated transcriptomic and machine learning approaches. PubMed 41409294
- Pathol Res Pract, 2025 (senior author): Pathomics predict CD40LG expression and clinical prognosis in lung adenocarcinoma based on haematoxylin-eosin-stained images. PubMed 40840227
- Respir Med, 2025 (senior author): Analysis and prediction of pathological risk factors for lung cancer by plasma metabolomics. PubMed 40623507
- Front Oncol, 2025 (senior author): Mapping the clinical trial landscape of multiple primary lung cancer in the era of precision oncology: persistent exclusion and design limitations hamper evidence-based treatment development. PubMed 40831938
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion